Changmao Biochemical Engineering Company Limited (0954.HK)
HKD 0.41
(-1.22%)
HKD 0.41
(-1.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.34 Million | 19.63 Million | -6.93 Million | 58.9 Million | 118.32 Million | 44.47 Million |
| Net Income | -58.58 Million | 87.64 Million | 84.4 Million | 17.15 Million | 62.55 Million | 54.6 Million |
| Depreciation & Amortization | 42.74 Million | 32.2 Million | 29.21 Million | 32.78 Million | 35.35 Million | 34.37 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -25.29 Million | -100.96 Million | -19.54 Million | 250 Thousand | 36.04 Million | -37.62 Million |
| Other non-cash items | 5.82 Million | 755 Thousand | -101.02 Million | 8.72 Million | -15.62 Million | -6.86 Million |
| Investing Cash Flow | -122.1 Million | -220.71 Million | -144.62 Million | 7.14 Million | -35.78 Million | -16.49 Million |
| Investments in PPE | -139.16 Million | -223.51 Million | -252.2 Million | -79.66 Million | -41.26 Million | -32.9 Million |
| Acquisitions | - | - | -10.7 Million | -2.67 Million | - | - |
| Investment purchases | - | - | -75.07 Million | 2.67 Million | - | - |
| Sales/Maturities of investments | - | 1.07 Million | 752 Thousand | 914 Thousand | 3.94 Million | 1.85 Million |
| Other Investing Activities | 15.21 Million | 1.73 Million | 192.62 Million | 85.9 Million | 1.53 Million | 14.55 Million |
| Financing Cash Flow | 153.83 Million | 199.54 Million | 76.74 Million | -49.75 Million | -45.15 Million | -15.33 Million |
| Debt repayment | -197.09 Million | -88.36 Million | -50 Million | -20.5 Million | -38.87 Million | -88.34 Million |
| Dividends payments | -42.33 Million | - | -10.59 Million | -29.13 Million | -26.48 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -926 Thousand | 287.91 Million | 137.33 Million | -122 Thousand | 20.2 Million | 73 Million |
| Accounts receivables | 12.94 Million | -18.05 Million | -25.7 Million | -34.93 Million | 35.41 Million | -5.4 Million |
| Accounts payables | - | 18.05 Million | 25.7 Million | 34.93 Million | -35.41 Million | - |
| Inventory | 16.08 Million | -55.61 Million | -4.09 Million | -19.18 Million | 1.14 Million | 7.31 Million |
| Other working capital | -5.61 Million | -45.35 Million | -15.44 Million | 19.43 Million | 34.89 Million | -44.93 Million |
| Cash at beginning of period | 59.99 Million | 58.17 Million | 133.69 Million | 119.31 Million | 81.39 Million | 68.75 Million |
| Cash at end of period | 89.55 Million | 59.99 Million | 58.17 Million | 133.69 Million | 119.31 Million | 81.39 Million |
| Capital Expenditure | -139.16 Million | -223.51 Million | -252.2 Million | -79.66 Million | -41.26 Million | -32.9 Million |
| Effect of forex changes on cash | 177 Thousand | 3.34 Million | -701 Thousand | -1.92 Million | 534 Thousand | 1000.00 |
| Net cash flow / Change in cash | 29.56 Million | 1.81 Million | -75.51 Million | 14.37 Million | 37.91 Million | 12.64 Million |
| Free Cash Flow | -141.51 Million | -203.88 Million | -259.14 Million | -20.76 Million | 77.06 Million | 11.57 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9.39 Million | -9.39 Million | -45.1 Million | -58.58 Million | -45.1 Million | 2.07 Million |
| Depreciation & Amortization | 11.05 Million | 11.05 Million | 10.74 Million | 42.74 Million | 10.74 Million | 10.62 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 11.7 Million | -25.29 Million | 11.7 Million | - |
| Other non-cash items | -14.94 Million | -14.94 Million | 31.66 Million | 5.82 Million | 31.66 Million | -22.89 Million |
| Investing Cash Flow | -21.41 Million | -21.41 Million | -32.32 Million | -122.1 Million | -32.32 Million | -28.73 Million |
| Investments in PPE | -26.7 Million | -26.7 Million | -33 Million | -139.16 Million | -33 Million | -36.57 Million |
| Acquisitions | - | - | - | - | - | 92.73 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 5.29 Million | 5.29 Million | 689 Thousand | 15.21 Million | 689 Thousand | 7.84 Million |
| Financing Cash Flow | 20.44 Million | 20.44 Million | 16.3 Million | 153.83 Million | 16.3 Million | 60.61 Million |
| Debt repayment | - | - | - | -197.09 Million | - | -140.54 Million |
| Dividends payments | - | - | -21.16 Million | -42.33 Million | -21.16 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 20.44 Million | 20.44 Million | 37.47 Million | - | 37.47 Million | 60.61 Million |
| Accounts receivables | - | - | 6.47 Million | 12.94 Million | 6.47 Million | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | 8.04 Million | 16.08 Million | 8.04 Million | - |
| Other working capital | - | - | -2.8 Million | -5.61 Million | -2.8 Million | - |
| Cash at beginning of period | - | - | - | 59.99 Million | - | 81.21 Million |
| Cash at end of period | -13.76 Million | -13.76 Million | -5.28 Million | 89.55 Million | -5.28 Million | 109.75 Million |
| Capital Expenditure | -26.7 Million | -26.7 Million | -33 Million | -139.16 Million | -33 Million | -36.57 Million |
| Effect of forex changes on cash | 494 Thousand | 494 Thousand | 1.7 Million | 177 Thousand | 1.7 Million | -1.61 Million |
| Net cash flow / Change in cash | -13.76 Million | -13.76 Million | -5.28 Million | 29.56 Million | -5.28 Million | 28.54 Million |
| Free Cash Flow | -39.99 Million | -39.99 Million | -23.99 Million | -141.51 Million | -23.99 Million | -46.76 Million |
CIGNITITEC
8275
BARRA
6920
RONY
2323